BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lubel JS, Roberts SK, Howell J, Ward J, Shackel NA. Current issues in the prevalence, diagnosis and management of hepatocellular carcinoma in Australia. Intern Med J 2021;51:181-8. [DOI: 10.1111/imj.15184] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Pan Y, Chang R, He Z, Hong M. How to prophylactically alleviate postembolization syndrome following transarterial chemoembolization?: Protocol of a double blinded, randomized, placebo-controlled trial. Medicine (Baltimore) 2021;100:e25360. [PMID: 33832116 DOI: 10.1097/MD.0000000000025360] [Reference Citation Analysis]
2 Li Z, Fang J, Chen S, Liu H, Zhou J, Huang J, Liu S, Peng Y. A Risk Model Developed Based on Necroptosis Predicts Overall Survival for Hepatocellular Carcinoma and Identification of Possible Therapeutic Drugs. Front Immunol 2022;13:870264. [PMID: 35422802 DOI: 10.3389/fimmu.2022.870264] [Reference Citation Analysis]